𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of sleep disturbance in Alzheimer's dementia

✍ Scribed by Oludamilola Salami; Constantine Lyketsos; Vani Rao


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
133 KB
Volume
26
Category
Article
ISSN
0885-6230

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Objective

To review the evidence‐base behind current treatment options for sleep disturbance in Alzheimer's dementia.

Design

A systematic review synthesized the qualitative and quantitative evidence on the treatment of sleep disturbance in Alzheimer's dementia. Studies with interventions targeting sleep disturbance in Alzheimer's dementia or other aspects of the neuropsychiatric symptoms, but which reported an effect on sleep, were included. The Oxford Center for Evidence‐Based Medicine criteria was used in the evaluation and scoring of each study based on the quality of the evidence.

Results

Thirty‐eight studies were included. Majority of the studies enrolled participants with mild to moderate Alzheimer's dementia. Outcome measures included objective sleep assessments including polysomnography (PSG) or actigraphy, caregiver reports, sleep logs, and rating scales. The effectiveness of current treatments for sleep disturbance in Alzheimer's dementia is poor. Of the non‐pharmacological treatments, bright light therapy (BLT) has the best results. The pharmacological agents produce inconsistent results and their use is further limited by their potential adverse effects.

Conclusion

Most current treatments targeting sleep disturbance in Alzheimer's dementia are ineffective. There is a need for further investigation of interventions for treating sleep disturbance in Alzheimer's dementia. Copyright © 2010 John Wiley & Sons, Ltd.


📜 SIMILAR VOLUMES


SELEGILINE IN THE TREATMENT OF BEHAVIOUR
✍ BRIAN A. LAWLOR; PAUL S. AISEN; CYNTHIA GREEN; ELIZABETH FINE; JAMES SCHMEIDLER 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

Objective. The purpose of this study was to examine the behavioural and cognitive eects of selegiline in a group of moderately behaviourally disturbed AD patients. Design. This was a 14-week randomized double-blind placebo-controlled study of selegiline (10 mg) and placebo. Setting. An outpatient

Behavioural disturbances in psychiatric
✍ Jen-Ping Hwang; Cheng-Hung Yang; Shih-Jen Tsai; King-Ming Liu 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

This report studied behavioural disturbances in psychiatric inpatients with dementia of the Alzheimer's type (DAT) in Taiwan. The sample consisted of 75 inpatients with DAT who were consecutively admitted to the geropsychiatric ward. Their behavioural disturbances were obtained from semistructured i

Sleep disturbances in Parkinson's diseas
✍ Matthew Menza; Roseanne DeFronzo Dobkin; Humberto Marin; Karina Bienfait 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

## Abstract Sleep disturbances are very common in patients with PD and are associated with a variety of negative outcomes. The evaluation of sleep disturbances in these patients is complex, as sleep may be affected by a host of primary sleep disorders, other primary medical or psychiatric condition

Brain quinolinic acid in Alzheimer's dem
✍ E. Sofic; J. Halket; A. Przyborowska; P. Riederer; H. Beckmann; M. Sandler; K. J 📂 Article 📅 1989 🏛 Springer-Verlag 🌐 English ⚖ 328 KB